Sana Biotechnology, Inc. (NASDAQ:SANA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Nelsen Other companies: City Therapeutics, Inc. (Board Director · Since at least Oct 19, 2026); Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Lyell Immunopharma, Inc. (Director · Jun 16, 2021 – Jun 14, 2024 · Past); Revolution Healthcare Acquisition Corp (Director · Mar 17, 2021 – Mar 17, 2021 · Past); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Mar 31, 2021 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 30, 2024 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Apr 13, 2021 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 18, 2020 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 2, 2021 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 8, 2017 · Past); Bellerophon Therapeutics Inc (Director · Feb 12, 2015 – Feb 13, 2015 · Past); Juno Therapeutics Inc (Director · Dec 18, 2014 – Mar 5, 2018 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Nov 9, 2015 · Past); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Oct 4, 2013 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Mar 3, 2017 · Past); Kythera Biopharmaceuticals Inc (Director · Oct 10, 2012 – Aug 14, 2014 · Past); NeurogesX Inc (Director · May 1, 2007 – Jun 7, 2012 · Past); Adolor Corp (Director · May 18, 2006 – May 17, 2007 · Past) | Director · Since at least Feb 3, 2021 |
| Mary Agnes Wilderotter Other companies: Okta, Inc. (Director · Since at least Aug 13, 2025); Fortinet, Inc. (Director · Since at least Apr 19, 2024); DocuSign, Inc. (Director · Since at least Apr 26, 2018); Costco Wholesale Corporation (Director · Since at least Oct 13, 2015); Lyft, Inc. (Director · Mar 28, 2019 – Aug 28, 2023 · Past); Cadence Design Systems, Inc. (Director · Jul 1, 2017 – Feb 14, 2020 · Past); DXC Technology Company (Director · Mar 15, 2017 – Mar 15, 2017 · Past); Hewlett Packard Enterprise Company (Director · Feb 10, 2016 – Apr 5, 2022 · Past); Dreamworks Animation SKG Inc (Director · Oct 22, 2015 – Aug 22, 2016 · Past); Juno Therapeutics Inc (Director · Dec 18, 2014 – Mar 5, 2018 · Past); Procter & Gamble Company (the) (Director · Aug 11, 2009 – Oct 15, 2015 · Past); Frontier Communications Corporation (Executive Chairman, Director · Nov 3, 2008 – Feb 26, 2016 · Past); Altaba Inc (Director · Jul 26, 2007 – Jun 25, 2009 · Past); The McClatchy Company (Director · May 17, 2006 – May 16, 2007 · Past); Xerox Holdings Corporation (Director · Mar 1, 2006 – Jul 15, 2015 · Past) | Director · Since at least Feb 3, 2021 |
| Douglas E. Williams Other companies: CAMP4 Therapeutics Corporation (Chairman of the Board · Since at least Mar 17, 2025); Climb Bio, Inc. (Chairman · Since at least Nov 8, 2024); Panacea Acquisition II Corp (Director · Apr 6, 2021 – Apr 6, 2021 · Past); Codiak BioSciences Inc (President & CEO, Director · Oct 13, 2020 – Mar 28, 2023 · Past); Ovid Therapeutics Inc. (Director · May 4, 2017 – May 17, 2021 · Past); Ironwood Pharmaceuticals, Inc. (Director · Jun 3, 2014 – Apr 1, 2019 · Past); Regulus Therapeutics Inc (Director · Nov 5, 2012 – Jun 2, 2016 · Past); Biogen Inc. (EVP Research & Development · Jan 10, 2011 – Jun 19, 2015 · Past); Cascadian Therapeutics Inc (Director · Oct 1, 2009 – Jun 13, 2013 · Past); Anadys Pharmaceuticals Inc (Director · Jun 2, 2006 – May 30, 2008 · Past) | EVP & President, R&D · Apr 10, 2023 – Mar 7, 2024 · Past |
| Douglas G Cole Other companies: Foghorn Therapeutics Inc. (Director · Since at least Oct 22, 2020); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 1, 2023 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Jan 2, 2019 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Aug 17, 2017 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Aug 10, 2016 · Past); Receptos Inc (Director · May 8, 2013 – Jul 17, 2013 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Mar 25, 2013 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – May 12, 2011 · Past) | Director · Feb 3, 2021 – Jun 6, 2024 · Past |
| Sunil Agarwal Other companies: Astria Therapeutics Inc (Director · Since at least Apr 5, 2024); Arvinas, Inc. (Director · Since at least Jun 15, 2023); Juno Therapeutics Inc (President of R & D · Apr 13, 2017 – Mar 5, 2018 · Past); MyoKardia Inc (Director · Mar 4, 2016 – Nov 17, 2020 · Past); Calithera Biosciences, Inc. (Director · Sep 29, 2015 – Jun 1, 2022 · Past); Ultragenyx Pharmaceutical Inc. (Chief Medical Officer · Aug 19, 2015 – Aug 19, 2016 · Past) | EVP, Head of Development & CMO · Feb 3, 2021 – Mar 3, 2022 · Past |
| Patrick Yang Other companies: Amyris Inc (Director · Jul 1, 2014 – Aug 5, 2020 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – May 20, 2014 · Past); Codexis, Inc. (Director · Feb 22, 2014 – Jun 14, 2022 · Past); Andeavor (Director · Dec 8, 2010 – Oct 1, 2018 · Past); Genentech Inc (EVP, Product Operations · Mar 26, 2009 – Mar 26, 2009 · Past) | Director · Since at least Feb 3, 2021 |
| Robert L Rosiello Other companies: Seres Therapeutics, Inc. (Director · Since at least Aug 5, 2025); Omega Therapeutics Inc (Director · Oct 2, 2024 – Oct 2, 2024 · Past); Evelo Biosciences, Inc. (Director · Apr 14, 2023 – Jun 8, 2023 · Past); Axcella Health Inc (Director · Oct 10, 2022 – Nov 16, 2022 · Past); Bausch Health Companies Inc. (EVP, Corp Dev & Strategy · Jun 11, 2015 – Dec 5, 2016 · Past) | Director · Since at least Jun 5, 2025 |
| Alise Reicin Other companies: Immatics N.V. (Director · Since at least Mar 18, 2026); Tectonic Therapeutic, Inc. (President and CEO, Director · Since at least Jun 20, 2024); Q32 Bio Inc. (Director · Jul 11, 2019 – Jun 14, 2023 · Past); Celgene Corporation (PRES., GLOBAL CLINICAL DEV. · Nov 1, 2018 – Nov 20, 2019 · Past) | Director · Since at least Feb 3, 2021 |
| Hans Bishop Other companies: Lyell Immunopharma, Inc. (Director · Jun 16, 2021 – Jun 14, 2024 · Past); Celgene Corporation (Director · Apr 18, 2018 – Nov 20, 2019 · Past); Agilent Technologies, Inc. (Director · Jul 18, 2017 – Mar 15, 2024 · Past); Juno Therapeutics Inc (CEO & President, Director · Jun 9, 2016 – Mar 5, 2018 · Past) | Chairman · Since at least Feb 3, 2021 |
| Joshua H Bilenker Other companies: Gossamer Bio, Inc. (Director · Feb 7, 2019 – Jun 9, 2022 · Past); T2 Biosystems, Inc. (Director · Aug 6, 2014 – Jun 17, 2016 · Past); Loxo Oncology Inc (President & CEO, Director · Jul 31, 2014 – Feb 15, 2019 · Past); Roka Bioscience Inc (Director · Jul 16, 2014 – Jul 16, 2014 · Past) | Director · Since at least Feb 3, 2021 |
| Richard Mulligan Other companies: International Flavors & Fragrances, Inc. (Director · Since at least Oct 20, 2025); Bausch Health Companies Inc. (Director · May 10, 2022 – May 16, 2025 · Past); Biogen Inc. (Director · Jun 10, 2009 – Jun 15, 2022 · Past); Viskase Holdings, Inc. (Director · May 21, 2009 – Jan 2, 2013 · Past) | Vice Chairman · Since at least Feb 3, 2021 |
| Bernard J Cassidy Other companies: Juno Therapeutics Inc (General Counsel & Secretary · Dec 18, 2014 – Mar 5, 2018 · Past); Tessera Technologies Inc (EVP & GC, TIPC President · Nov 17, 2008 – Mar 6, 2013 · Past); Tumbleweed Communications Corp (SVP,General Counsel &Secretary · Apr 24, 2007 – Sep 3, 2008 · Past) | EVP & General Counsel · Sep 12, 2022 – Mar 6, 2025 · Past |
| Michelle Seitz Other companies: Honeywell Aerospace Inc (Director · Since at least Jun 29, 2026); MetLife, Inc. (Director · Since at least Feb 24, 2026); MSCI Inc. (Director · Since at least Aug 5, 2024) | Director · Since at least Feb 3, 2021 |
| Brian Piper Other companies: Prelude Therapeutics Incorporated (Chief Financial Officer · Sep 24, 2020 – Aug 25, 2021 · Past); Aevi Genomic Medicine LLC (CFO & Corporate Secretary · Feb 9, 2016 – Jun 14, 2018 · Past) | Executive Vice President, Chief Financial Officer · Since at least Feb 17, 2026 |
| Steve Harr Other companies: Loxo Oncology Inc (Director · Nov 7, 2016 – Feb 15, 2019 · Past); Juno Therapeutics Inc (CFO & Head, Corp. Development · Dec 18, 2014 – Mar 5, 2018 · Past) | President & CEO, Director · Since at least Feb 3, 2021 |
| Geoffrey von Maltzahn Other companies: Kaleido Biosciences, Inc. (Director · Feb 27, 2019 – Jun 30, 2021 · Past) | Director · Feb 3, 2021 – Feb 8, 2021 · Past |
| Susan D Wyrick Other companies: Achieve Life Sciences, Inc. (PAO · Feb 1, 2013 – Mar 14, 2014 · Past) | See Remarks · Since at least Oct 4, 2024 |
| Aaron Grossman | Executive Vice President, Chief Legal Officer · Since at least Nov 4, 2026 |
| Christian Hordo | EVP, Chief Business Officer · Feb 3, 2021 – Mar 7, 2024 · Past |
| Dhavalkumar Patel | Executive Vice President, Chief Scientific Officer · Since at least Mar 24, 2026 |
| Gary Meininger | Executive Vice President, Chief Medical Officer · Since at least Jul 13, 2026 |
| James J MacDonald | EVP & General Counsel · Feb 3, 2021 – Jun 13, 2022 · Past |
| Jim MacDonald | Chief Executive Officer and member of its Board of Directors · Sep 16, 2025 – Nov 4, 2026 · Past |
| Josh Bilenker | Director · Since at least Nov 4, 2026 |
| Nathan Hardy | EVP, Chief Financial Officer · Feb 3, 2021 – Mar 7, 2024 · Past |
| Rob Rosiello | Director · Since at least Nov 4, 2026 |
| Snehal Patel | Executive Vice President, Chief Technical Officer · Since at least Nov 4, 2026 |
| Steve Harr | President and Chief Executive Officer · Since at least Aug 10, 2026 |